APLLTDBSEAlembic Pharmaceuticals LtdMinimalNeutral
Announced Mon, 6 Apr · 14:38 IST

The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CRA Family Trust

APLLTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+5.6%1-day move
₹656.20
prior close
₹651.05
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3+0.7+0.8+1.4+5.6+11.9+9.7+10.1+9.1+14.3+15.8+19.6+13.7+27.2
Up moveDown movePending
AI summary

CRA Family Trust, a shareholder entity based in Vadodara, has submitted its annual compliance certificate for the financial year ended 31st March, 2026. The certificate, issued by Chartered Accountants M/s. D. K. Mehta & Co., confirms that the Trust has complied with the conditions of a SEBI Exemption Order granted on 30th September, 2020. This filing is a routine regulatory requirement under Regulation 10(6) of the SEBI Takeover Regulations. The compliance pertains to clause 6(ix) of the exemption order, with the certificate issued under clause 6(x) for submission to stock exchanges and SEBI.

Likely market impact

This is a routine compliance filing with no immediate impact on shareholders. It confirms that CRA Family Trust continues to operate within the conditions of its SEBI exemption, meaning no material change in shareholding or control structure is being reported.